Volume 25, Number 7—July 2019
Research
High-Complexity Plasmodium falciparum Infections, North Central Nigeria, 2015–2018
Figure 2
![Screening PCR results of persons with Plasmodium falciparum parasite infections, North Central Nigeria, 2015–2018. Lane M, 50-bp DNA marker (ThermoFisher Scientific, https://www.thermofisher.com); lanes 1–4, archived blood samples from Nisa Premier Hospital (Jabi, Federal Capital Territory, Nigeria); lanes 5–15, archived blood samples from Kogi Specialist Hospital (Lokoja, Kogi State, Nigeria); lane 16, positive control. Samples positive for P. falciparum had a PCR product size of 205 bp.](/eid/images/18-1614-F2.jpg)
Figure 2. Screening PCR results of persons with Plasmodium falciparum parasite infections, North Central Nigeria, 2015–2018. Lane M, 50-bp DNA marker (ThermoFisher Scientific, https://www.thermofisher.com); lanes 1–4, archived blood samples from Nisa Premier Hospital (Jabi, Federal Capital Territory, Nigeria); lanes 5–15, archived blood samples from Kogi Specialist Hospital (Lokoja, Kogi State, Nigeria); lane 16, positive control. Samples positive for P. falciparum had a PCR product size of 205 bp.
Page created: August 19, 2019
Page updated: August 19, 2019
Page reviewed: August 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.